Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alamar Biosciences, Inc.ALMR · Entity 1791 | General Counsel | September 14, 2026 | September 16, 2026 |
| Outset Medical, Inc.OM · Entity 7026 | General Counsel | August 17, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alamar Biosciences, Inc.
Report date September 14, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,000 |
Reported balance
After 2026-09-14 transaction · row 1
1 source rowRow 1 · 2026-09-14 · Grant · Acquired 29,000 · Balance 29,000 F1: Represents a restricted stock unit ("RSU") award. One-quarter of the RSUs will vest on November 21, 2027 and the remainder of the RSUs will vest in twelve equal quarterly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.99 · Expires 2036-09-13 | Direct | 85,000 |
Reported balance
After 2026-09-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-14 · Grant · Acquired 85,000 · Balance 85,000 F2: One-quarter of the total shares subject to the option will vest on September 14, 2027 and the remainder of the shares subject to the grant will vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award. One-quarter of the RSUs will vest on November 21, 2027 and the remainder of the RSUs will vest in twelve equal quarterly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.
F2: One-quarter of the total shares subject to the option will vest on September 14, 2027 and the remainder of the shares subject to the grant will vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.
Outset Medical, Inc.
Report date August 17, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 87,475 |
Reported balance
After 2026-08-17 transaction · row 1
1 source rowRow 1 · 2026-08-17 · Sale · Disposed 2,632 · Balance 87,475 F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2021 Filed Dec 2, 2021 21:42 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,500 | $47.92 | $167,720.00 |
DisclosureSEC source: 0001484612-21-000089 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,047 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 21:42 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 3,500 | $9.48 | $33,180.00 |
DisclosureSEC source: 0001484612-21-000089 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 21:18 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 3,500 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-21-000077 · edgardoc.xml · derivative · entry 6 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,765 Underlying: Common Stock · 3,500 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 21:18 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,445 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-21-000077 · edgardoc.xml · derivative · entry 5 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,228 Underlying: Common Stock · 1,445 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 21:18 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,445 | $51.03 | $73,738.35 |
DisclosureSEC source: 0001484612-21-000077 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,047 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 21:18 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,445 | $9.48 | $13,698.60 |
DisclosureSEC source: 0001484612-21-000077 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 21:18 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,500 | $51.55 | $180,418.35 |
DisclosureSEC source: 0001484612-21-000077 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,047 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $51.00-$51.99 - 3,000 shares; $52.00-$52.99 - 500 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 21:18 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 3,500 | $9.48 | $33,180.00 |
DisclosureSEC source: 0001484612-21-000077 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 19, 2021 Filed Oct 19, 2021 20:58 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,445 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-21-000070 · edgardoc.xml · derivative · entry 5 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,673 Underlying: Common Stock · 1,445 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| October 19, 2021 Filed Oct 19, 2021 20:58 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,445 | $50.00 | $72,250.00 |
DisclosureSEC source: 0001484612-21-000070 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,047 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. Read SEC document |
| October 19, 2021 Filed Oct 19, 2021 20:58 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,445 | $9.48 | $13,698.60 |
DisclosureSEC source: 0001484612-21-000070 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:58 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 3,500 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-21-000070 · edgardoc.xml · derivative · entry 6 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,265 Underlying: Common Stock · 3,500 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:58 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,500 | $49.02 | $171,567.90 |
DisclosureSEC source: 0001484612-21-000070 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,047 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $48.60 to $49.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:58 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 3,500 | $9.48 | $33,180.00 |
DisclosureSEC source: 0001484612-21-000070 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 21:35 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 3,500 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-21-000059 · edgardoc.xml · derivative · entry 6 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,765 Underlying: Common Stock · 3,500 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 21:35 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,445 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-21-000059 · edgardoc.xml · derivative · entry 5 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,118 Underlying: Common Stock · 1,445 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 21:35 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,445 | $50.44 | $72,892.01 |
DisclosureSEC source: 0001484612-21-000059 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,047 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $50.01 to $50.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 21:35 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,445 | $9.48 | $13,698.60 |
DisclosureSEC source: 0001484612-21-000059 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 21:35 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,500 | $50.31 | $176,080.10 |
DisclosureSEC source: 0001484612-21-000059 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,047 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $49.92 to $50.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 21:35 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 3,500 | $9.48 | $33,180.00 |
DisclosureSEC source: 0001484612-21-000059 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2021 Filed Sep 7, 2021 22:29 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,445 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-21-000058 · edgardoc.xml · derivative · entry 6 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,563 Underlying: Common Stock · 1,445 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| September 07, 2021 Filed Sep 7, 2021 22:29 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,445 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-21-000058 · edgardoc.xml · derivative · entry 5 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,008 Underlying: Common Stock · 1,445 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| September 07, 2021 Filed Sep 7, 2021 22:29 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,445 | $50.00 | $72,250.00 |
DisclosureSEC source: 0001484612-21-000058 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,047 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. Read SEC document |
| September 07, 2021 Filed Sep 7, 2021 22:29 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,445 | $9.48 | $13,698.60 |
DisclosureSEC source: 0001484612-21-000058 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2021 Filed Sep 7, 2021 22:29 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,445 | $50.00 | $72,250.00 |
DisclosureSEC source: 0001484612-21-000058 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,047 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. Read SEC document |
| September 07, 2021 Filed Sep 7, 2021 22:29 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,445 | $9.48 | $13,698.60 |
DisclosureSEC source: 0001484612-21-000058 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 375 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2021 to August 31, 2021. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| August 16, 2021 Filed Aug 16, 2021 22:28 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 3,500 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-21-000053 · edgardoc.xml · derivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,265 Underlying: Common Stock · 3,500 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
| August 16, 2021 Filed Aug 16, 2021 22:28 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,500 | $38.68 | $135,387.35 |
DisclosureSEC source: 0001484612-21-000053 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,672 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $38.35 to $38.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. Read SEC document |
| August 16, 2021 Filed Aug 16, 2021 22:28 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 3,500 | $9.48 | $33,180.00 |
DisclosureSEC source: 0001484612-21-000053 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2021 Filed Jul 15, 2021 23:55 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 3,500 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-21-000042 · edgardoc.xml · derivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,765 Underlying: Common Stock · 3,500 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
| July 15, 2021 Filed Jul 15, 2021 23:55 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,500 | $43.83 | $153,392.40 |
DisclosureSEC source: 0001484612-21-000042 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,672 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $43.54 to $44.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. Read SEC document |
| July 15, 2021 Filed Jul 15, 2021 23:55 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 3,500 | $9.48 | $33,180.00 |
DisclosureSEC source: 0001484612-21-000042 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2021 Filed Jun 18, 2021 00:08 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,445 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-21-000024 · edgardoc.xml · derivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,453 Underlying: Common Stock · 1,445 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| June 17, 2021 Filed Jun 18, 2021 00:08 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,445 | $50.00 | $72,250.00 |
DisclosureSEC source: 0001484612-21-000024 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,672 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. Read SEC document |
| June 17, 2021 Filed Jun 18, 2021 00:08 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,445 | $9.48 | $13,698.60 |
DisclosureSEC source: 0001484612-21-000024 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 01:05 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 3,500 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-21-000023 · edgardoc.xml · derivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,265 Underlying: Common Stock · 3,500 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 01:05 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,500 | $47.87 | $167,535.90 |
DisclosureSEC source: 0001484612-21-000023 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,672 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $47.32 to $48.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 01:05 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 3,500 | $9.48 | $33,180.00 |
DisclosureSEC source: 0001484612-21-000023 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2021 Filed May 18, 2021 16:38 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 3,500 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-21-000006 · edgardoc.xml · derivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,765 Underlying: Common Stock · 3,500 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
| May 17, 2021 Filed May 18, 2021 16:38 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,500 | $42.34 | $148,192.45 |
DisclosureSEC source: 0001484612-21-000006 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,672 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $41.67 to $42.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote (2). Read SEC document |
| May 17, 2021 Filed May 18, 2021 16:38 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 3,500 | $9.48 | $33,180.00 |
DisclosureSEC source: 0001484612-21-000006 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 20:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Stock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0000905148-21-000365 · form4.xml · derivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,265 Underlying: Common Stock · 3,500 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lock-up period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 20:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 195 | $54.98 | $10,721.10 |
DisclosureSEC source: 0000905148-21-000365 · form4.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,672 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 20:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,305 | $54.12 | $178,876.85 |
DisclosureSEC source: 0000905148-21-000365 · form4.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,867 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $53.85 to $54.555, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 20:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 3,500 | $9.48 | $33,180.00 |
DisclosureSEC source: 0000905148-21-000365 · form4.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 21:53 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Stock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001140361-21-009379 · form4.xml · derivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,765 Underlying: Common Stock · 3,500 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lock-up period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 21:53 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 294 | $48.73 | $14,326.62 |
DisclosureSEC source: 0001140361-21-009379 · form4.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,672 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 21:53 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,206 | $47.61 | $152,650.80 |
DisclosureSEC source: 0001140361-21-009379 · form4.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,966 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $47.33 to $48.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1). Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 21:53 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 3,500 | $9.48 | $33,180.00 |
DisclosureSEC source: 0001140361-21-009379 · form4.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 01:11 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantStock Option (Right to Buy) · Derivative | 22,209 | $0.00 Strike: $25.89 | $0.00 |
DisclosureSEC source: 0001140361-21-008972 · form4.xml · derivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,209 Underlying: Common Stock · 22,209 shares Expires 2031-03-14 F3 · derivative.exercise_date: This option vests 25% on March 15, 2022, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.